Replies to post #145878 on ORIONS Money Stocks

[califax]

APRI - Apricus Biosciences Announces Presentation of Efficacy and Clinical Safety Data for Vitaros(R) at Upcoming Industry Conference

http://ih.advfn.com/p.php?pid=nmona&article=49481882

...The poster presentation will discuss additional subgroup analyses on a combined dataset from two pivotal Phase 3 clinical trials in 1,732 patients suffering from erectile dysfunction ("ED"). The data further demonstrates the efficacy and safety of Vitaros® as an easy-to-administer, topical first-line treatment option for all ED patients, independent of age, body mass index ("BMI") and risk factors, such as cardiovascular disease and diabetes.